149 related articles for article (PubMed ID: 11208286)
21. Primary colorectal lymphoma.
Aragón Sánchez FJ; García Molina FJ; Rodríguez Fernández A; de Dios Franco Osorio J; Ortegón Castellano B; Márquez Platero R; López Hurtado M; Medina Díez J
Rev Esp Enferm Dig; 1997 Dec; 89(12):903-18. PubMed ID: 9494378
[TBL] [Abstract][Full Text] [Related]
22. Malignant non-Hodgkin's lymphoma (NHL) in childhood. Retrospective analysis of 34 cases.
Wagner HP; Bleher EA; Bürki K; Delaleu B; Grétillat P; Kühner U; Pedrinis E
Helv Paediatr Acta; 1977 Nov; 32(4-5):331-42. PubMed ID: 617979
[TBL] [Abstract][Full Text] [Related]
23. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
[TBL] [Abstract][Full Text] [Related]
24. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
[TBL] [Abstract][Full Text] [Related]
25. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
26. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
28. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
29. Treatment options for primary splenic low-grade non-Hodgkin's lymphomas.
Musteata VG; Corcimaru IT; Iacovleva IA; Musteata LZ; Suharschii IS; Antoci LT
Clin Lab Haematol; 2004 Dec; 26(6):397-401. PubMed ID: 15595997
[TBL] [Abstract][Full Text] [Related]
30. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
Davidson KL; Devaney MB; Tighe JE; Rogers SY; Dunlop DJ; Mackie MJ; Thomas RV; Johnson PR;
Haematologica; 2003 Dec; 88(12):1366-71. PubMed ID: 14687989
[TBL] [Abstract][Full Text] [Related]
31. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of early stage primary tonsil non-Hodgkin's lymphoma].
Gao YH; Li YX; Zhao LJ; Yuan ZY; Liu XF; Yu ZH
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):190-2. PubMed ID: 12864949
[TBL] [Abstract][Full Text] [Related]
34. [Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)].
Wróbel G; Kazanowska B; Chybicka A; Jeleń M; Małdyk J; Sowińska E; Balcerska A; Balwierz W; Bubała H; Kołakowska-Mrozowska B; Kołtan A; Korzon M; Kowalczyk J; Krawczuk-Rybak M; Maciejka-Kapuścińska L; Matysiak M; Płoszyńska A; Popadiuk S; Solarz E; Sońta-Jakimczyk D; Sopyło B; Stańczak E; Stefaniak J; Stefańska K; Wachowiak J; Wieczorek M; Wysocki M
Przegl Lek; 2004; 61 Suppl 2():45-8. PubMed ID: 15686045
[TBL] [Abstract][Full Text] [Related]
35. [Primary non-Hodgkin's lymphomas of the colon: apropos of a case with double localization].
Montini F; Di Mascio DE; Fossaceca R; Frino F; Angelucci D; Errichi BM
Chir Ital; 1994; 46(5):59-65. PubMed ID: 7788813
[TBL] [Abstract][Full Text] [Related]
36. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E;
Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990
[TBL] [Abstract][Full Text] [Related]
37. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
38. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Aydin S; Dührsen U; Nückel H
Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
[TBL] [Abstract][Full Text] [Related]
39. Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Zinzani PL; Tani M; Molinari AL; Stefoni V; Zuffa E; Alinari L; Gabriele A; Bonifazi F; Salvucci M; Tura S; Baccarani M
Haematologica; 2002 Aug; 87(8):816-21. PubMed ID: 12161357
[TBL] [Abstract][Full Text] [Related]
40. Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation.
Fu P; van Heeckeren WJ; Wadhwa PD; Bajor DJ; Creger RJ; Xu Z; Cooper BW; Laughlin MJ; Gerson SL; Koç ON; Lazarus HM
Contemp Clin Trials; 2008 Mar; 29(2):157-64. PubMed ID: 17707140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]